Categories AlphaGraphs, Earnings, Retail
Yum! Brands reports 1% decline in Q4 revenue, earnings miss
Yum! Brands (YUM) said its revenue for the fourth quarter fell 1% to $1.56 billion, falling short of the projection of $1.59 billion set by analysts. On an adjusted basis, the KFC-parent earned 40 cents per share, less than half of 97 cents per share that the street had expected.
YUM shares fell 1.6% during pre-market trading. The stock has gained 18% in the past 52 weeks and is currently trading near an all-time high.
On the same-store sales front, meanwhile, the company managed to impress with a 3% growth worldwide. Taco Bell was the best performer with a 6% growth, which was followed by KFC with a modest 3% increase. Same-store sales at the Pizza Hut division was flat during the quarter.
CEO Greg Creed said, “Combined across our brands and led by over 2,000 world-class franchisees, we opened a record 8 gross new restaurants per day across the globe in 2018. As we move into 2019, we will continue to pursue even more growth, leverage our unprecedented scale, and maximize value for all Yum! stakeholders.”
Through its refranchising program launched in 2016, the company has been aiming at achieving better sales growth. It needs to be noted that the company-owned stores have witnessed a slump in sales in the recent quarters.
Last month, the company appointed David Gibbs as its new president and chief operating officer as part of bringing innovation to the operations.
Yesterday, shares of rival Chipotle Mexican Grill popped over 7% after reporting better-than-expected results, helped by a 6.1% increase in comparable restaurant sales and new restaurant openings.
Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on